Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.100
0.00 (0.00%)
At close: May 28, 2025, 4:00 PM
1.180
+0.080 (7.27%)
Pre-market: May 29, 2025, 5:12 AM EDT

Acrivon Therapeutics Market Cap

Acrivon Therapeutics has a market cap or net worth of $34.49 million as of May 28, 2025. Its market cap has decreased by -86.28% in one year.

Market Cap
34.49M
Enterprise Value
-111.63M
1-Year Change
-86.28%
Ranking
Category
Stock Price
$1.10

Market Cap Chart

Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $34.49M, a decrease of -85.33%. That is a compound annual growth rate of -53.15%.

History

DateMarket Cap% Change
May 27, 202534.49M-81.60%
Dec 31, 2024187.44M71.66%
Dec 29, 2023109.20M-54.61%
Dec 30, 2022240.59M2.33%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 645.82B
Johnson & Johnson 366.76B
AbbVie 323.41B
Novo Nordisk 305.07B
UnitedHealth Group 270.43B
Abbott Laboratories 229.69B
Novartis AG 219.70B
AstraZeneca 216.88B
Market Cap Rankings